Diseases Preventable by Traditional Vaccines

Last updated July 1, 2025

Vaccines have transformed global health by preventing millions of deaths each year from once-deadly diseases. Traditional vaccines remain a critical line of defense against highly contagious infections like polio, diphtheria, pertussis, tetanus, and measles. This guide explores each of these vaccine-preventable diseases, highlighting how immunization has changed their impact—and why continued vigilance still matters.

Polio

Polio is a serious viral infection that primarily affects children under the age of three, though people of any age can be infected. It spreads through contact with contaminated feces or respiratory secretions and quickly establishes itself in the intestines before potentially entering the bloodstream.

In severe cases, the virus invades the nervous system, destroying the nerve cells that control muscles—often leading to paralysis, especially in the legs. In the worst cases, it can affect the brainstem and cause respiratory failure or death.

There is no treatment or cure for polio, making prevention through immunization the only effective defense. Since the introduction of the first successful polio vaccines in 1955, the disease has been largely eliminated from industrialized nations.

The global effort to eradicate polio took a major leap in 1988, when the World Health Assembly committed to eliminating the disease worldwide. This sparked coordinated campaigns led by national governments, WHO, UNICEF, and Rotary International.

In just over a decade, reported polio cases dropped from an estimated 350,000 annually to around 3,500 by the year 2000. Large regions of the world, including the Americas, Western Pacific, and Europe, have since been declared polio-free.

However, outbreaks can still occur in areas where immunization programs have broken down due to war or instability. As of 2000, the remaining reservoirs in South Asia and West/Central Africa remained top targets for intensified eradication efforts.

Diphtheria

Diphtheria is a bacterial infection caused by Corynebacterium diphtheriae, and it spreads primarily through respiratory droplets during close person-to-person contact.

While some individuals show only mild or no symptoms, others may develop severe throat and respiratory infections that can obstruct breathing. In serious cases, the infection can cause lasting damage to the heart and nervous system. In tropical regions, the skin may also be affected, leading to additional complications.

Even with treatment, diphtheria remains a deadly disease—about one in ten people infected will die. The risk is especially high in communities with limited access to healthcare or where vaccination coverage is low. Outbreaks have occurred in recent decades, including large-scale epidemics in Russia and other Eastern European countries, where adults have also been affected, demonstrating the importance of maintaining lifelong immunity and strong public health monitoring.

A safe and reliable vaccine against diphtheria has been available for many years and is typically administered as part of the DTP (diphtheria, tetanus, pertussis) combination vaccine.

This approach helps provide broad protection during early childhood. Continued immunization efforts, especially in areas experiencing social or economic disruption, are essential to preventing resurgence and ensuring the disease does not regain a foothold.

Pertussis (Whooping Cough)

Pertussis, also known as whooping cough, is a highly contagious bacterial infection caused by Bordetella pertussis. It spreads through droplets released by coughing or sneezing and can be transmitted by direct contact.

The disease is most dangerous for young infants, who often suffer from prolonged and violent coughing fits that can last for several weeks or even months. These fits can be exhausting and may lead to complications such as vomiting, broken ribs, and difficulty breathing.

Globally, pertussis causes an estimated 296,000 deaths each year, with over 45 million people affected annually. Beyond persistent coughing, some children experience severe complications such as seizures or long-term neurological damage.

Despite decades of vaccine use, the disease continues to circulate, partly because immunity—whether from infection or vaccination—tends to wane over time. This explains why outbreaks have been reported even in high-income countries, particularly among adolescents and adults who were vaccinated in early childhood.

Vaccination remains the most effective way to prevent pertussis. There are two main types of vaccines: whole-cell and acellular. Whole-cell vaccines use the entire killed bacterium and have been in use for decades, while acellular vaccines contain only specific parts of the bacterium and are associated with fewer side effects.

Although both are effective, acellular vaccines are more expensive and typically used in wealthier countries. Maintaining high vaccination coverage and timely booster doses is crucial to keeping the disease under control.

Tetanus

Tetanus is a life-threatening bacterial infection caused by Clostridium tetani, a bacterium commonly found in soil, animal waste, and human feces. It enters the body through cuts, puncture wounds, or other breaks in the skin, especially when these wounds are exposed to unsanitary conditions.

Once inside the body, the bacterium produces a powerful toxin that affects the nervous system and causes intense muscle stiffness and spasms. When the facial muscles are affected, it results in a condition known as lockjaw. If the respiratory muscles are impacted, breathing can become difficult or impossible, often leading to death without timely intervention.

Neonatal tetanus is a particularly deadly form of the disease that affects newborns, primarily due to unhygienic delivery practices or improper care of the umbilical cord. Most of these cases occur in low-resource settings where skilled birth attendants and sterile tools are unavailable.

Although preventable, neonatal tetanus still causes approximately 200,000 deaths each year. When including older children and adults, WHO estimates the total number of tetanus-related deaths annually is over 500,000, making it a significant global health concern.

Safe and effective tetanus vaccines have existed for decades and are commonly administered as part of the DTP combination. Efforts to eliminate neonatal tetanus gained international attention after the 1993 World Summit for Children.

WHO and its partners advocate for two key strategies: ensuring pregnant women receive at least two doses of the vaccine, and promoting clean delivery practices. When these steps are followed, both neonatal and general tetanus cases can be drastically reduced.

Measles

Measles is a highly contagious viral illness caused by a member of the paramyxovirus family. It spreads easily through respiratory droplets when an infected person coughs or sneezes, and its incubation period typically ranges from 7 to 18 days.

Symptoms often begin with a high fever, cough, and runny nose, followed by a red rash that usually spreads from the face downward. Additional complications can include conjunctivitis, diarrhea, and ear infections, especially in young children.

While measles can cause mild illness in some individuals, it can also lead to severe and sometimes permanent consequences. One of the most serious complications is encephalitis, or brain inflammation, which can result in brain damage, blindness, or deafness.

Measles is particularly deadly in low-income countries and among malnourished children, where access to medical care and nutrition is limited. Worldwide, the virus is responsible for an estimated 777,000 deaths annually, making it one of the leading causes of vaccine-preventable mortality.

There is no specific antiviral treatment for measles, which makes prevention through vaccination essential. While supportive care like hydration and vitamin A supplementation can reduce the risk of death, the most effective approach remains immunization.

Maintaining high coverage is especially important to prevent outbreaks, as the virus is so contagious that even small gaps in vaccination can lead to rapid spread. Global vaccination campaigns have significantly reduced measles deaths, but continued investment is necessary to protect vulnerable populations.

Conclusion

Traditional vaccines remain one of the most effective tools in global public health, offering reliable protection against deadly diseases like polio, diphtheria, pertussis, tetanus, and measles.

These vaccines have saved millions of lives and drastically reduced the burden of preventable illness, especially among children in vulnerable communities. Yet, the continued presence of outbreaks and disparities in access remind us that progress is fragile and must be actively sustained.

Maintaining high vaccination coverage, investing in healthcare infrastructure, and promoting public awareness are essential to preventing the resurgence of these diseases. As global health systems evolve, the lessons from decades of vaccine success should guide future strategies—not just for new immunizations, but for preserving the gains we’ve already made.

The fight against vaccine-preventable diseases isn’t over, but with consistent effort, their impact can continue to shrink year after year.